Medicamen Organics Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Medicamen Organics Ltd is ₹ 26 as of 15 May 15:30 . The P/E Ratio of Medicamen Organics Ltd is 0 as of March 2024 .The P/E Ratio of Procter & Gamble Health Ltd is 0 as of March 2024 . The Market Cap of Medicamen Organics Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Procter & Gamble Health Ltd is ₹ 0 crore as of March 2024 . The revenue of Medicamen Organics Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Procter & Gamble Health Ltd for the Sep '25 is ₹ 329.87 crore as compare to the Jun '25 revenue of ₹ 342.77 crore. This represent the decline of -3.76% The ebitda of Medicamen Organics Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Procter & Gamble Health Ltd for the Sep '25 is ₹ 125.22 crore as compare to the Jun '25 ebitda of ₹ 94.37 crore. This represent the growth of 32.69% The net profit of Medicamen Organics Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 88.54 crore over 6 quarters. This represents a CAGR of 53.49% The dividend payout of Medicamen Organics Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Medicamen Organics Ltd

Medicamen Organics Limited was formerly incorporated on March 15, 1995 as Panchdeep Pharmaceuticals Limited', as Public Limited Company dated March 15, 1995 issued by the Registrar of Companies, Delhi and Haryana.
Subsequently, the name of Company changed to Medicamen Organics Limited' and a fresh Certificate of Incorporation on November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi. Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry Powders for Government (including both State and Central Governments) and Private Institutions as contract manufacturer / third party manufacturer.
The product portfolio consists of 84 products and comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS).

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Medicamen Organics Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Medicamen Organics Ltd or Procter & Gamble Health Ltd?

Market cap of Medicamen Organics Ltd is 30 Cr while Market cap of Procter & Gamble Health Ltd is 8,775 Cr

What are the key factors driving the stock performance of Medicamen Organics Ltd and Procter & Gamble Health Ltd?

The stock performance of Medicamen Organics Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medicamen Organics Ltd and Procter & Gamble Health Ltd?

As of May 18, 2026, the Medicamen Organics Ltd stock price is INR ₹26.0. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5286.55.

How do dividend payouts of Medicamen Organics Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Medicamen Organics Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.